Kazia Therapeutics Net Debt Growth & History (KZIA)
Kazia Therapeutics's net debt was −$3.9M for fiscal 2025.
View full Kazia Therapeutics company overviewKazia Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | −$3.9M | −$2.9M | — |
| 2024 | 2024-06-30 | −$1.0M | $2.4M | — |
| 2023 | 2023-06-30 | −$3.4M | $2.1M | — |
| 2022 | 2022-06-30 | −$5.5M | — | — |
| 2018 | 2018-06-30 | −$5.9M | $8.6M | — |
| 2017 | 2017-06-30 | −$14.4M | — | — |
Kazia Therapeutics quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | −$69.4M | −$66.4M | — |
| Q4 2025 | 2025-06-30 | −$3.9M | −$2.9M | — |
| Q2 2025 | 2024-12-31 | −$2.9M | $279,731 | — |
| Q4 2024 | 2024-06-30 | −$1.0M | $2.4M | — |
| Q2 2024 | 2023-12-31 | −$3.2M | $634,906 | — |
| Q4 2023 | 2023-06-30 | −$3.4M | $2.1M | — |
| Q2 2023 | 2022-12-31 | −$3.8M | — | — |
| Q4 2022 | 2022-06-30 | −$5.5M | — | — |
| Q4 2018 | 2018-06-30 | −$5.9M | — | — |
Kazia Therapeutics net debt trends
Between the periods ended 2017-06-30 and 2025-06-30, Kazia Therapeutics's net debt increased from −$14.4M to −$3.9M, a change of $10.5M. The latest reported quarter, Q2 2026, shows −$69.4M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kazia Therapeutics source filings ↗